CYCN — Cyclerion Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1755237 ·
Last close
$3.93
Market Cap
$17.02M
52W High
$4.47
52W Low
$2.96
ADV30
28,504
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -1,771,000 | -1,755,000 | 6,930,000 | 1,391,000 | 1,843,000 |
| Mar 2026 | 0 | — | -3,209,000 | -3,177,000 | 8,505,000 | 2,823,000 | 1,714,000 |
| Dec 2025 | 1,025,000 | — | -838,000 | -799,000 | 9,985,000 | 3,240,000 | 900,000 |
| Sep 2025 | 875,000 | — | -1,006,000 | -976,000 | 10,415,000 | 4,568,000 | 877,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,451,000
Investing CF
$-66,000
Financing CF
$2,902,000
CapEx
$-66,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.58
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-275,952,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-6,824,000
Pretax Income TTM
$-6,707,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,900,000
EBITDA
—
Free Cash Flow
$-2,075,000
Enterprise Value
$16,715,772
Total Cash
$1,391,000
Total Debt
$0
Shares Out
4,330,314
Trailing EPS
$-1.66
Book Value
$1.20
ROE
-98.2%
ROA
-52.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,074,000 | -4,973,000 | -3,528,000 | 9,985,000 | 900,000 | — | -3,314,000 |
| Dec 2024 | 2,000,000 | -3,628,000 | -3,057,000 | 9,575,000 | 725,000 | — | -4,333,000 |
| Dec 2023 | 0 | -9,647,000 | -5,263,000 | 13,374,000 | 2,086,000 | — | -21,245,000 |
| Dec 2022 | 297,000 | -18,540,000 | -44,078,000 | 18,079,000 | 7,627,000 | — | -40,611,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.31
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LPCN | Lipocine Inc. | $16.98M | $2.06 | — |
| CALC | CalciMedica, Inc. | $17.10M | $0.56 | — |
| KTTA | Pasithea Therapeutics Corp. | $16.87M | $0.50 | — |
| LEXX | Lexaria Bioscience Corp. | $17.42M | $10.54 | — |
| SCNX | Scienture Holdings, Inc. | $17.76M | $0.43 | — |
News headlines (Yahoo Finance, 1h cache)
Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer’s Pipeline
2026-04-20 14:15 · Yahoo
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?
2026-04-02 13:15 · Yahoo
Top Midday Gainers
2026-04-01 17:51 · Yahoo
CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26
2026-02-23 11:53 · Yahoo
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
2026-02-17 12:00 · Yahoo
CYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics…
2026-02-02 12:14 · Yahoo
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
2026-01-05 21:01 · Yahoo
Akebia Therapeutics Sets Rare Kidney Drug Plan After Q32 Bio Deal
2025-12-01 13:40 · Yahoo
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network
2025-11-10 14:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.